Breaking News Instant updates and real-time market news.

MYL

Mylan

$36.53

-0.33 (-0.90%)

10:53
12/01/17
12/01
10:53
12/01/17
10:53

Mylan receives final FDA approval for ANDAs for Heparin Sodium Injection USP

Mylan announced it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Applications for Heparin Sodium Injection USP, 1,000 USP/mL, 5,000 USP/mL, 10,000 USP/mL, and 20,000 USP/mL, all of which are packaged in multi-dose vials. Heparin is a complex injectable used as an anticoagulant in blood transfusions, extracorporeal circulation and dialysis procedures to prevent and treat various types of blood clots and to treat atrial fibrillation with embolization. Mylan's president Rajiv Malik commented, "We are very proud of today's FDA approval of Heparin Sodium Injection as this approval adds yet another highly complex and difficult-to-manufacture product to our portfolio. Our investments over the last decade in our scientific and manufacturing capabilities, particularly in the injectables space, continue to pay off as we create a leading portfolio and a robust pipeline of complex products that differentiate us amongst our peers."

  • 03

    Dec

MYL Mylan
$36.53

-0.33 (-0.90%)

11/07/17
SUSQ
11/07/17
NO CHANGE
Target $47
SUSQ
Positive
Mylan positioned to deliver near-term growth, says Susquehanna
Susquehanna analyst Andrew Finkelstein believes Mylan is favorably positioned relative to peers to deliver near-term growth despite headwinds while advancing a long-term strategy. He said the shares warrant a premium to traditional peers who face tougher growth challenges. Finkelstein reiterated his Positive rating and raised his price target to $47 from $43 on Mylan.
11/07/17
RBCM
11/07/17
NO CHANGE
Target $37
RBCM
Sector Perform
Mylan price target raised to $37 from $32 at RBC Capital
RBC Capital analyst Randall Stanicky raised his price target on Mylan to $37 and kept his Sector Perform rating. The analyst says that in spite of two consecutive challenging quarters that showed the company is not immune to broader sector challenges, Mylan's relative positioning remains favorable to peers, adding that generic Copaxone performance is helpful in the near term.
12/01/17
WELS
12/01/17
NO CHANGE
WELS
Wells not seeing Amazon talks as good news for Mylan, others
CNBC last night reported that Amazon.com (AMZN) is in exploratory talks with Mylan (MYL) and Novartis' Sandoz (NVS) regarding a potential entry into the pharmacy space. While the market might consider this good news for Mylan and other generics as a sign of potential preferred supplier agreements, Wells Fargo analyst David Maris says he's more cautious. Amazon entering the pharmacy market could be a negative headwind for retail generics and potentially branded over-the-counter products, Maris argues. He believes Amazon would source at competitive prices and that "increased price transparency may cause traditional retailers to push harder for price concessions."
12/01/17
WELS
12/01/17
NO CHANGE
Target $1525
WELS
Outperform
Amazon price target raised to $1,525 from $1,430 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Amazon.com (AMZN) to $1,525 to reflect increased outer-year estimates for Web Services as well as a higher sum-of-the-parts valuation. The stock closed yesterday up $15.48 to $1,176.75. The analyst highlights the "very successful" five-day Amazon Wed Services conference in Las Vegas, "record-breaking" early holiday sales data, and another healthcare industry development with CNBC reporting the company is in talks with generic manufacturers Mylan (MYL) and Novartis (NVS). Sena sees an increasing likelihood that Amazon "ultimately becomes a disruptor" in healthcare, with generics representing a potential point of entry. The Wells Fargo Healthcare team sees generics as a "simple entry point" in pharma as it involves many players with ready supply and a price competitive market, Sena tells investors in a research note. The analyst keeps an Outperform rating on Amazon.

TODAY'S FREE FLY STORIES

PFE

Pfizer

$36.46

-0.18 (-0.49%)

19:32
12/14/17
12/14
19:32
12/14/17
19:32
Hot Stocks
Pfizer announces FDA approval of Xeljanz »

Pfizer announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

HUSKF

Husky Energy

$12.76

0.3377 (2.72%)

18:44
12/14/17
12/14
18:44
12/14/17
18:44
Upgrade
Husky Energy rating change  »

Husky Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRAH

PRA Health

$89.13

1.9 (2.18%)

18:41
12/14/17
12/14
18:41
12/14/17
18:41
Initiation
PRA Health initiated  »

PRA Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$110.57

2.96 (2.75%)

, FOX

21st Century Fox

$34.22

1.88 (5.81%)

18:31
12/14/17
12/14
18:31
12/14/17
18:31
Periodicals
Experts: Disney-Fox deal may raise antitrust worries, Reuters reports »

Competition experts say…

DIS

Disney

$110.57

2.96 (2.75%)

FOX

21st Century Fox

$34.22

1.88 (5.81%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

MESO

Mesoblast

$5.39

-0.07 (-1.28%)

, TIG

TiGenix

$21.67

-2.55 (-10.53%)

18:31
12/14/17
12/14
18:31
12/14/17
18:31
Hot Stocks
Mesoblast grants TiGenix exclusive global license for stem cells treatment »

Mesoblast (MESO) has…

MESO

Mesoblast

$5.39

-0.07 (-1.28%)

TIG

TiGenix

$21.67

-2.55 (-10.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$12.14

0.15 (1.25%)

18:28
12/14/17
12/14
18:28
12/14/17
18:28
Hot Stocks
MiMedx posts new materials on website exposing misinformation from short sellers »

MiMedx announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

, GOOG

Alphabet

$1,049.15

8.54 (0.82%)

18:23
12/14/17
12/14
18:23
12/14/17
18:23
Periodicals
Amazon to begin selling Apple TV, Chromecast on online store, Reuters reports »

Amazon (AMZN) plans to…

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

GOOG

Alphabet

$1,049.15

8.54 (0.82%)

GOOGL

Alphabet Class A

$1,057.47

6.08 (0.58%)

AAPL

Apple

$172.22

-0.05 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 18

    Mar

WM

Waste Management

$84.66

-0.68 (-0.80%)

18:02
12/14/17
12/14
18:02
12/14/17
18:02
Hot Stocks
Waste Management raises quarterly dividend 9.4%, authorizes $1.25B buyback »

Waste Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQV

Iqvia

$101.47

-0.75 (-0.73%)

17:58
12/14/17
12/14
17:58
12/14/17
17:58
Initiation
Iqvia initiated  »

Iqvia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRE

Sempra Energy

$115.78

0.54 (0.47%)

17:40
12/14/17
12/14
17:40
12/14/17
17:40
Hot Stocks
Sempra Energy, Oncor announce settlement with key stakeholders »

Oncor Electric Delivery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:40
12/14/17
12/14
17:40
12/14/17
17:40
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

, AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

17:34
12/14/17
12/14
17:34
12/14/17
17:34
Hot Stocks
Breaking Hot Stocks news story on Oracle, Amazon.com »

Oracle says switching…

ORCL

Oracle

$50.19

0.14 (0.28%)

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Mar

EPD

Enterprise Products

$26.07

0.17 (0.66%)

17:33
12/14/17
12/14
17:33
12/14/17
17:33
Hot Stocks
Enterprise Products to implement further oil quality specifications at Cushing »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:31
12/14/17
12/14
17:31
12/14/17
17:31
Hot Stocks
Adobe 'pleased' with subscription bookings and advertising cloud »

Says photography offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

, COST

Costco

$186.53

-1.75 (-0.93%)

17:30
12/14/17
12/14
17:30
12/14/17
17:30
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Jabil…

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

COST

Costco

$186.53

-1.75 (-0.93%)

CNC

Centene

$99.02

-2.17 (-2.14%)

DCIX

Diana Containerships

$4.87

-0.37 (-7.06%)

MS

Morgan Stanley

$52.64

-0.54 (-1.02%)

DDR

DDR Corp.

$7.96

-0.11 (-1.36%)

RMBL

RumbleON

$5.30

-0.06 (-1.12%)

SAH

Sonic Automotive

$20.05

-0.95 (-4.52%)

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

FORM

FormFactor

$14.90

-0.05 (-0.33%)

ORCL

Oracle

$50.19

0.14 (0.28%)

VSTM

Verastem

$3.65

-0.15 (-3.95%)

GBT

Global Blood Therapeutics

$39.40

1.05 (2.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

  • 09

    Jan

AEP

American Electric

$76.29

-0.22 (-0.29%)

17:28
12/14/17
12/14
17:28
12/14/17
17:28
Syndicate
Breaking Syndicate news story on American Electric »

American Electric files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$158.03

-6.62 (-4.02%)

17:25
12/14/17
12/14
17:25
12/14/17
17:25
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Dinner Meeting will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

ORCL

Oracle

$50.20

0.14 (0.28%)

17:24
12/14/17
12/14
17:24
12/14/17
17:24
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Hurd says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:23
12/14/17
12/14
17:23
12/14/17
17:23
Hot Stocks
Adobe targeting subscription bookings growth of 20% in FY18 »

Says expect quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Adobe says advertising cloud had a 'strong' year »

Says advertising cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says currency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:19
12/14/17
12/14
17:19
12/14/17
17:19
Earnings
Oracle sees Q3 adjusted EPS 68c-70c, consensus 72c »

Sees Q3 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

, UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

17:17
12/14/17
12/14
17:17
12/14/17
17:17
Hot Stocks
Urstadt Biddle raises quarterly dividend by 0.5c to 27c »

At their regular meeting…

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
Oracle says customer adoption of cloud products 'remains very strong' »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NQ

NQ Mobile

$4.13

0.02 (0.49%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
NQ Mobile announces partnership with Chery Automotive »

NQ Mobile Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.